Simplex Trading, LLC Acurx Pharmaceuticals, Inc. Transaction History
Simplex Trading, LLC
- $175 Billion
- Q2 2025
A detailed history of Simplex Trading, LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 6,889 shares of ACXP stock, worth $32,584. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,889
Previous 1,400
392.07%
Holding current value
$32,584
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ACXP
# of Institutions
28Shares Held
2.05MCall Options Held
62.9KPut Options Held
56.9K-
Armistice Capital, LLC New York, NY1.08MShares$5.1 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$692,4900.0% of portfolio
-
Morgan Stanley New York, NY106KShares$502,3300.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny87.8KShares$415,2040.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.85KShares$402,0500.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $54.7M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...